Valuation: Perrigo Company plc

Market Cap 1.4B 1.23B 1.14B 1.05B 1.97B 135B 2B 13.55B 5.3B 66.17B 5.25B 5.13B 229B P/E 2026 *
-72.1x
P/E 2027 * 8.71x
Enterprise Value 4.34B 3.81B 3.54B 3.25B 6.11B 418B 6.2B 42.06B 16.43B 205B 16.28B 15.93B 710B EV / Sales 2026 *
1.07x
EV / Sales 2027 * 1.03x
Free-Float
99.6%
Yield 2026 *
11.4%
Yield 2027 * 11.7%
1 day+0.10%
1 week-5.51%
Current month-2.51%
1 month+3.78%
3 months-14.31%
6 months-29.66%
Current year-27.24%
1 week 9.86
Extreme 9.86
10.83
1 month 9.56
Extreme 9.56
11.59
Current year 9.22
Extreme 9.225
15.38
1 year 9.22
Extreme 9.225
28.44
3 years 9.22
Extreme 9.225
40.28
5 years 9.22
Extreme 9.225
50.9
10 years 9.22
Extreme 9.225
99.14
Manager TitleAgeSince
Chief Executive Officer 63 2026-06-06
Director of Finance/CFO 51 2022-05-15
Chief Operating Officer - 2025-06-22
Director TitleAgeSince
Director/Board Member 75 2014-10-31
Director/Board Member 61 2016-11-06
Director/Board Member 70 2017-02-05
Date Insider Type Main position Quantity % Market Cap.
7/8/26 Other

General Counsel

123,704 0.0894%
7/8/26 Other

Director

14,964 0.0108%
7/8/26 Other

Chief Technology Officer

84,826 0.0613%
Change 5-day change 1-year change 3-year change Capi.($)
+0.10%-5.51%-63.97%-71.38% 1.4B
+0.61%+1.08%+47.98%+159.49% 1,057B
+1.50%+4.08%+55.33%+53.95% 624B
+0.85%+1.74%+35.68%+80.84% 454B
+1.60%+6.25%+33.95%+29.84% 341B
-0.60%+1.52%+35.68%+39.76% 297B
-0.14%+0.60%+16.17%+17.53% 262B
+0.09%-2.82%-28.29%-41.71% 215B
+1.45%+2.98%+22.25%+60.23% 201B
-0.63%-3.02%+15.04%+67.69% 162B
Average +0.55%-0.25%+16.98%+39.62% 361.54B
Weighted average by Cap. +0.74%+1.56%+35.57%+77.33%

Financials

2026 *2027 *
Net sales 4.06B 3.56B 3.31B 3.04B 5.71B 391B 5.8B 39.34B 15.37B 192B 15.23B 14.9B 664B 4.1B 3.6B 3.35B 3.07B 5.77B 395B 5.86B 39.75B 15.53B 194B 15.39B 15.05B 671B
Net income -339M -298M -277M -254M -477M -32.65B -485M -3.29B -1.28B -16.05B -1.27B -1.25B -55.49B 161M 142M 132M 121M 227M 15.54B 231M 1.57B 612M 7.64B 606M 593M 26.42B
Net Debt 2.94B 2.58B 2.4B 2.2B 4.14B 283B 4.2B 28.51B 11.14B 139B 11.03B 10.8B 481B 2.83B 2.48B 2.31B 2.12B 3.98B 272B 4.04B 27.43B 10.72B 134B 10.62B 10.39B 463B
Logo Perrigo Company plc
Perrigo Company plc is a pure-play self-care company. The Company provides health and wellness solutions. Its segments include Self Care, Specialty Care, and Infant Formula. Self Care comprises Upper Respiratory, Digestive Health, Pain & Sleep and Healthy Lifestyle product categories globally. Specialty Care comprises our Women's Health and Skin Health product categories globally. Infant Formula comprises the Infant Formula product category, which includes nutritional products designed to meet the dietary needs of infants. It provides a store-branded private label provider of self-care products in many categories, including upper respiratory, healthy lifestyle and women's health, along with brands including Opill and Mederma. Its Europe portfolio consists primarily of brands, including Compeed, ellaOne, Solpadeine, Jungle Formula, and ACO. Its upper respiratory products include Nasonex 24HR Energy, Mucus DM, All Day Allergy, Nighttime Cold & Flu, and Allergy Relief.
Employees
8,100
Date Price Change Volume
26-07-24 US$10.12 +0.20% 1,461,826
26-07-23 US$10.10 -3.53% 3,013,556
26-07-22 US$10.47 0.00% 2,798,515
26-07-21 US$10.47 -1.13% 1,849,363
26-07-20 US$10.59 -1.21% 2,333,452
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
10.10USD
Average target price
16.50USD
Spread / Average Target
+63.37%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PRGO Stock